We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lactate Added to Critical Care Analyzer Menu

By LabMedica International staff writers
Posted on 30 Apr 2012
A lactate assay has become available for cartridge-based critical care testing at the Point of Care (POC). More...
Lactate joins an already extensive assay menu that includes blood gas, electrolytes, metabolites, and CO-oximetry.

Siemens (Erlangen, Germany) continues to expand the assay menu of its RAPIDPoint 500 critical care analyzer. The easy-to-use RAPIDPoint 500 system uses Siemens technology to deliver rapid and accurate test results in approximately 60 seconds.

The value of measuring lactate levels is expanding. Though generally considered a nonspecific biomarker, knowing lactate levels early in a patient’s presentation can provide valuable information to help guide patient assessment and treatment.

It can be particularly useful in the Intensive Care Unit (ICU) and Emergency Department (ED) settings where the presentation of symptoms may be inconclusive while diseases progress rapidly with severe pathology; lactate testing can open a critical window for early intervention when treatment is most likely to be successful. This allows clinicians to quickly gain diagnostic information for treatment planning.

Afia Boamah, blood gas and stratus CS product manager at Siemens Healthcare Diagnostics, stated, “The addition of Lactate to the already extensive assay range on the RAPIDPoint 500 follows an extremely successful Controlled Release Program. Over 21,000 samples were run with zero cartridge failures attributable to the lactate sensor. Such results underpin the confidence we have in our cartridge based technology and the functionality it adds to the RAPIDPoint 500 System.”

The RAPIDPoint 500 Lactate Cartridge received the CE Marking, December 16, 2011. RAPIDPoint 500 Analyzer received the CE Marking, September 26, 2011.

Related Links:

Siemens Healthcare Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.